Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Medical Oncology Physician in Tampa, FL
NPI: 1407949944Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Patrick's Phone Numberphone_androidMobile
Get M.D. Patrick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
FL State Medical License
2020 - 2027
TX State Medical License
2004 - 2027
OK State Medical License
2020 - 2021
MD State Medical License
1990 - 2004
American Board of Internal Medicine
Medical Oncology
National Institutes of Health Clinical Center
Fellowship • Hematology and Medical Oncology
1989 - 1992
Johns Hopkins University
Residency • Internal Medicine
1987 - 1989
MCP-Hahnemann College of Medicine
Medical School
Until 1987
Authors: Moir, S, Lapointe, R, Malaspina, A, Ostrowski, M, Cole, C E, Chun, T W, Adelsberger, J, Baseler, M, Hwu, P, Fauci, A S
Journal: J Virol
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients.
Authors: Somedeb Ball, Jeffrey Lancet, Ning Dong, Brett Leav
Journal: Cancer Commun (Lond)
Publication Date: 2023-06-28
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, BIOLOGICAL: Aldesleukin, DRUG: Fludarabine Phosphate, BIOLOGICAL: CXCR2-transduced Autologous Tumor Infiltrating Lymphocytes, BIOLOGICAL: NGFR-transduced Autologous T Lymphocytes
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Cyclophosphamide, BIOLOGICAL: Aldesleukin, DRUG: Fludarabine Phosphate, BIOLOGICAL: NGFR-transduced Autologous T Lymphocytes, BIOLOGICAL: TGFbDNRII-transduced Autologous Tumor Infiltrating Lymphocytes
Lead Sponsor: M.D. Anderson Cancer Center
Intervention / Treatment: DRUG: gp100, DRUG: R848 gel, DRUG: MAGE-3